Target-based drug discovery for human African trypanosomiasis: selection of molecular target and chemical matter
- PMID: 23931634
- PMCID: PMC3884840
- DOI: 10.1017/S0031182013001017
Target-based drug discovery for human African trypanosomiasis: selection of molecular target and chemical matter
Abstract
Target-based approaches for human African trypanosomiasis (HAT) and related parasites can be a valuable route for drug discovery for these diseases. However, care needs to be taken in selection of both the actual drug target and the chemical matter that is developed. In this article, potential criteria to aid target selection are described. Then the physiochemical properties of typical oral drugs are discussed and compared to those of known anti-parasitics.
Figures
References
-
- Arrowsmith J. (2011a). Phase III and submission failures: 2007–2010. Nature Reviews Drug Discovery 10, 87 - PubMed
-
- Arrowsmith J. (2011b). Trial watch: phase II failures: 2008–2010. Nature Reviews Drug Discovery 10, 328–329 - PubMed
-
- Barrett M. P. (1999). The fall and rise of sleeping sickness. Lancet 353, 1113–1114 - PubMed
-
- Barrett M. P. (2006). The rise and fall of sleeping sickness. Lancet 367, 1377–1378 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
